73858 Novel Regulatory T-cell enhancing Biologic Rezpegaldesleukin: Phase 2b Efficacy, Safety, and Baseline Severity–Dependent Treatment Response in Moderate-to-Severe Atopic DermatitisSohail Chaudhry, Jonathan Zalevsky, David Rosmarin et al.|Journal of the American Academy of Dermatology|2026Cited by 0